The DNA damage-dependent intra–S phase checkpoint is regulated by parallel pathways
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
To preserve genetic integrity, mammalian cells exposed to ionizing radiation activate the ATM kinase, which initiates a complex response-including the S-phase checkpoint pathways-to delay DNA replication. Defects in ATM or its substrates Nbs1 or Chk2 (ref. 3), the Nbs1-interacting Mre11 protein, or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS). It is unknown, however, whether these proteins operate in a common signaling cascade. Here we show that experimental blockade of either the Nbs1-Mre11 function or the Chk2-triggered events leads to a partial RDS phenotype in human cells. In contrast, concomitant interference with Nbs1-Mre11 and the Chk2-Cdc25A-Cdk2 pathways entirely abolishes inhibition of DNA synthesis induced by ionizing radiation, resulting in complete RDS analogous to that caused by defective ATM. In addition, Cdk2-dependent loading of Cdc45 onto replication origins, a prerequisite for recruitment of DNA polymerase, was prevented upon irradiation of normal or Nbs1/Mre11-defective cells but not cells with defective ATM. We conclude that in response to ionizing radiation, phosphorylations of Nbs1 and Chk2 by ATM trigger two parallel branches of the DNA damage-dependent S-phase checkpoint that cooperate by inhibiting distinct steps of DNA replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, different treatment protocols may account for the discrepancy between the A-T-like phenotype of A-TLD(S) cells observed by us and the moderate cellular phenotype reported for these cells by Stewart et al. (1999) and Falck et al. (2002).”
From Requirement of the MRN complex for ATM activation by DNA damage (2003) · cites this paper as Falck et al. (2002)
Citations
Cites
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939 · cited 1×
“Moreover, as components of both the ATM-Nbs1-Mre11 and the ATM-Chk2-Cdc25A-cyclin E/Cdk2 branches are mutated or deregulated in cance”
BackgroundDNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085 · cited 1×
“, or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS”
BackgroundSelf-citationStewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060 · cited 1×
“, or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS”
BackgroundSelf-citation(1999) · PubMed · Cited by 1,030
Méndez, J., & Stillman, B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8602-8612.2000 · Cited by 915 · cited 1×
“We isolated chromatin from U-2-OS/VP16 cells and lymphoblasts as describe”
MethodAtaxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 829
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789 · cited 1×
“The nexus of S-phase regulation seems to be the origin, as in normal cells, DNA damage induces the inhibition of DNA replication origins while ongoing DNA replication forks are not affecte”
BackgroundATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., & Kastan, M. B. (2000) · Nature · doi:10.1038/35007091 · Cited by 786 · cited 1×
“Either the entire intra–S phase checkpoint, the Nbs1-Mre11 or the Chk2-Cdc25A-Cdk2 branch can be blocked by ectopic ATM-k”
BackgroundSelf-citationThe many substrates and functions of ATM.
Kastan, M. B., & Lim, D.-S. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043058 · Cited by 779
Cited by
Items 201–300 of 401
A Positive Role for the Ku Complex in DNA Replication Following Strand Break Damage in Mammals
Park, S.-J., Ciccone, S. L. M., Freie, B. W., Kurimasa, A., Chen, D. J., Li, G. C., Clapp, D. W., & Lee, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311054200 · Cited by 40
Zhong, X., Luo, G., Zhou, X., Luo, W., Wu, X., Zhong, R., Wang, Y., Xu, F., & Wang, J. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12274 · Cited by 35
Willis, N. A., & Rhind, N. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0798 · Cited by 35
“Replication slowing in metazoans is catalyzed by parallel pathways acting downstream of the central checkpoint kinases (Falck et al., 2002; Henry-Mowatt et al., 2003).”
BackgroundInfluentialThe Initiation Step of Eukaryotic DNA Replication
Pospiech, H., Große, F., & Pisani, F. M. (2009) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-3471-7_5 · Cited by 43
Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer
Chung, S., Vail, P. J., Witkiewicz, A. K., & Knudsen, E. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1620 · Cited by 39
“In part, the inhibition of DNA replication is mediated by the suppression of CDK2 activity (23, 24).”
BackgroundHistone H2AX participates the DNA damage-induced ATM activation through interaction with NBS1
Kobayashi, J., Tauchi, H., Chen, B., Bruma, S., Tashiro, S., Matsuura, S., Tanimoto, K., Chen, D. J., & Komatsu, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.109 · Cited by 40
“Radiationresistant DNA synthesis was analyzed as described in the previous report [16].”
MethodCell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage
Yang, Y., Durando, M., Smith-Roe, S. L., Sproul, C., Greenwalt, A. M., Kaufmann, W., Oh, S., Hendrickson, E. A., & Vaziri, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1325 · Cited by 33
“The G1-specificity of ATM activation by H2O2 in our experiments is also unexpected, as ATM is well known to mediate DSB-induced S-phase checkpoints (52,53).”
BackgroundRink, L. A., Słupianek, A., Stokłosa, T., Nieborowska-Skorska, M., Urbańska, K., Seferyńska, I., Reiss, K., & Skórski, T. (2007) · Blood · doi:10.1182/blood-2006-08-042630 · Cited by 35
Zhao, T., Sun, Q., Rincon, S. V. D., Lovato, A., Marques, M., & Witcher, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092853 · Cited by 34
“Chk1 and Chk2 activation are key mediators of S to G2 phase progression and activation of Chk2 in particular controls an intra-S phase checkpoint resulting in cell cycle arrest within S phase [22].”
BackgroundCytostatic and Cytotoxic Effects of Topotecan Decoded by a Novel Mathematical Simulation Approach
Lupi, M., Matera, G., Branduardi, D., D’Incalci, M., & Ubezio, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3810 · Cited by 33
“This should be in agreement with the theory that ATM activates a pathway of inhibition of DNA synthesis after double-strand breakage (16) and is also a possible explanation of the slowing down of the BrdUrd-positive cells in S phase that we quantify in our simulation.”
ResultEbi, H., Matsuo, K., Sugito, N., Suzuki, M., Osada, H., Tajima, K., Ueda, R., & Takahashi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1749 · Cited by 36
S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11–induced apoptosis of prostate cancer cells
Ray, S., Shyam, S., Fraizer, G. C., & Almasan, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0414 · Cited by 32
“Loss of Cdc25A phosphatase activity results in inhibition of S-phase– promoting cyclin E-cyclin-dependent kinase 2 (Cdk2) kinase activity (10) and of DNA replication (11).”
BackgroundJoerges, C., Kuntze, I., & Herzinge, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206613 · Cited by 32
“Evidence for such a parallel, yet ATM-dependent, pathway involving the Nbs1/Mre11/Rad50 complex has been provided recently (Falck et al., 2002).”
BackgroundRedundancy, insult-specific sensors and thresholds: unlocking the S-phase checkpoint response
Cobb, J. A., Shimada, K., & Gasser, S. M. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.04.001 · Cited by 35
“The superposition of DSB-induced and fork-associated signaling pathways may be responsible for the complexity of the mammalian checkpoint response to ionizing radiation [5 ].”
BackgroundThe Nijmegen breakage syndrome gene and its role in genome stability
Iijima, K., Komatsu, K., Matsuura, S., & Tauchi, H. (2004) · Chromosoma · doi:10.1007/s00412-004-0298-0 · Cited by 34
“The extent of RDS in NBS cells is milder than that in cells deficient in ATM, suggesting that the intra-S-phase checkpoint is regulated by two parallel branches that are triggered by ATM (Falck et al. 2002).”
BackgroundNBN Phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaks
Wen, J., Cerosaletti, K. M., Schultz, K. J., Wright, J. A., & CONCANNON, P. J. (2012) · Oncogene · doi:10.1038/onc.2012.443 · Cited by 31
Huang, L. H., Liao, X., Beckett, M., Li, Y., Khanna, K. K., Wang, Z., Kharbanda, S. M., Weichselbaum, R. R., & Kufe, D. W. (2010) · Genes & Cancer · doi:10.1177/1947601910368059 · Cited by 30
Improving the selectivity of cancer treatments by interfering with cell response pathways
Damia, G. L. M., & Broggini, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.020 · Cited by 29
“A permanent arrest during DNA replication would be detrimental, because it would limit the amount of template that is available for efficient repair by homologous recombination and could cause the inappropriate re-start of DNA synthesis in areas where it has already been started, with the risk of over-replication of p…”
BackgroundResveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway
Sui, X., Zhang, C.-J., Zhou, J., Cao, S., Xu, C., Tang, F., Zhi, X., Chen, B., Wang, S., & Yin, L. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0601-6 · Cited by 30
“hibitor p21, leading to the down-regulation of cyclins and cell cycle arrest [52, 53].”
BackgroundDeregulation of the Cell Cycle by the Epstein–Barr Virus
O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 32
Agner, J., Falck, J., Lukas, J., & Bártek, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.035 · Cited by 30
Self-citationGenetic changes and DNA damage responses in the prostate
af Hällström, T., & Laiho, M. (2008) · The Prostate · doi:10.1002/pros.20746 · Cited by 31
“Inactivation, mutation, or depletion of any of these proteins results in RDS [162–164].”
BackgroundInfluentialHong, B., Lui, V. W. Y., Hui, E. P., Ng, M. H. L., Cheng, S.-H., Sung, F. L., Tsang, C., Tsao, S., & Chan, A. T. �. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9356-z · Cited by 27
“Such an accumulation of inactive CDK2 will halt cell cycle progression through the S-phase [35, 42].”
BackgroundParsels, L. A., Parsels, J. D., Tai, D. C.-H., Coughlin, D. J., & Maybaum, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3040 · Cited by 27
Koledova, Z. S., Kafkova, L. R., Krämer, A., & Divoký, V. (2010) · Stem Cells · doi:10.1002/stem.311 · Cited by 27
Cui, B., Johnson, S. P., Bullock, N., Ali‐Osman, F., Bigner, D. D., & Friedman, H. S. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60057-7 · Cited by 30
“3A), suggesting that TMZ-induced DNA methylation damages were not preferentially repaired in the resistant GBM cells. γ-H2AX failed to localize to sites of DNA damages in the resistant GBM cells DNA DSBs arise from processing of O6-meG:C and O6-meG:T mismatches by the DNA repair apparatus[14,28].”
BackgroundInfluentialWang, X., Guan, J., Hu, B., Weiss, R. S., Iliakis, G. E., & Wang, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh243 · Cited by 33
RetractedInitiation of DNA replication in xenopus egg extracts
Arias, E. E. (2004) · Frontiers in bioscience · doi:10.2741/1457 · Cited by 25
“cells, γ-irradiation activates ATM kinase, leading to inhibition of Cdk2 activity and a block to Cdc45 loading (105).”
BackgroundStacey, D. W. (2010) · Genes & Cancer · doi:10.1177/1947601911403475 · Cited by 33
Role of Chk1 and Chk2 in Ara‐C‐induced differentiation of human leukemia K562 cells
Takagaki, K., Katsuma, S., Kaminishi, Y., Horio, T., Tanaka, T., Ohgi, T., & Yano, J. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00821.x · Cited by 24
“Taken together with these results, our findings suggest that Ara-C-induced Chk1 activation is mainly mediated by ATR, as is the case with other genotoxic agents, and that Ara-C-induced Chk2 activation may be mediated by species other than ATM, ATR and DNA-PK.”
BackgroundInfluentialDNA Damage and Polyploidization
Chow, J. P. H., & Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0_4 · Cited by 28
Wu, P., & Shen, C. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq054 · Cited by 23
Callaghan, C. M., Abukhiran, I. M., Masaadeh, A. H., Rheeden, R. V. V., Kalen, A. L., Rodman, S. N., Petronek, M. S., Mapuskar, K. A., George, B. N., Coleman, M. C., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.10.012 · Cited by 23
Fiévet, A., Bellanger, D., Valence, S., Mobuchon, L., Afenjar, A., Giuliano, F., d’Enghien, C. D., Parfait, B., Pedespan, J., Auger, N., et al. (2019) · Human Mutation · doi:10.1002/humu.23773 · Cited by 23
DNA Damage Checkpoint, Damage Repair, and Genome Stability
Liu, W., Yu, S., Chen, G., & Li, Y. (2006) · Acta Genetica Sinica · doi:10.1016/s0379-4172(06)60064-4 · Cited by 32
Innes, C. L., Heinloth, A. N., Flores, K. G., Sieber, S. O., Deming, P. B., Bushel, P. R., Kaufmann, W. K., & Paules, R. S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0154 · Cited by 21
“Ataxia telangiectasia (AT) is an autosomal-recessive, hereditary syndrome characterized by neuronal degeneration, telangiectasias, immunodeficiencies, lymphoid cancers (1), and cell cycle checkpoint defects in cultured cells (2, 3).”
BackgroundIntegrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts
Barkley, L. R., Ohmori, H., & Vaziri, C. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0032-7 · Cited by 21
“Consistent with a Cdc25A/CDK2-mediated mechanism for the S-phase checkpoint, association of Cdc45 with origins of replication (a late CDK2-dependent event in initiation of DNA replication), is inhibited in response to IR concomitant with Cdc25A degradation [86].”
BackgroundEngstrom, J. U., & Kmiec, E. B. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-9 · Cited by 20
“This activation, in turn, leads to a phosphorylation of the downstream checkpoint kinases, Chk1 and Chk2 at Ser317 and/or Ser 345 and at Thr68, respectively [22,42-45].”
BackgroundCao, P., McHugh, M. M., Melendy, T., & Beerman, T. A. (2003) · PubMed · Cited by 20
The Role of E3 Ligase Pirh2 in Disease
Daks, A. A., Fedorova, O., Parfenyev, S. E., Nevzorov, I. A., Shuvalov, O. Y., & Barlev, N. A. (2022) · Cells · doi:10.3390/cells11091515 · Cited by 21
Jia, X.-Z., Yang, S., Zhou, J., Li, S., Ni, J., An, G., & Jia, H. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.008 · Cited by 19
“Loading of CDC45 onto DNA, which is required for recruiting DNA polymerase a into assembled pre-initiation complexes at the origins of DNA, requires the activity of CDK2 [32,45].”
BackgroundInfluentialMammalian DNA Damage Response Pathway
Lou, Z., & Chen, J. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_15 · Cited by 22
Xavier, S., MacDonald, S., Roth, J., Caunt, M., Akalu, A., Morais, D., Buckley, M. T., Liebes, L., Formenti, S. C., & Brooks, P. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.010 · Cited by 23
Genetic heterogeneity for a Nijmegen breakage‐like syndrome
Maraschio, P., Spadoni, E., Tanzarella, C., Antoccia, A., di Masi, A., Maghnie, M., Varon, R., Demuth, I., Tiepolo, L., & Danesino, C. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00054.x · Cited by 20
“The formation of hMre11–Rad50 nuclear foci in response to ionizing radiation is impaired by nibrin deficiency, the latter also causing defective responses to DNA damage, including radio-resistant DNA synthesis (9, 10).”
BackgroundBoice, A., Lopez, K. E., PANDITA, R. K., Parsons, M. J., Charendoff, C. I., Charaka, V., Carisey, A. F., Pandita, T. K., & Bouchier‐Hayes, L. (2021) · Oncogene · doi:10.1038/s41388-021-02085-w · Cited by 20
Checkpoint regulation of replication forks: global or local?
Iyer, D., & Rhind, N. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130197 · Cited by 22
Cellular‐signaling pathways unveil the carcinogenic potential of chemicals
Hendriks, G., van de Water, B., Schoonen, W. G. E. J., & Vrieling, H. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2845 · Cited by 20
“Activated Chk1 targets various proteins involved in cell-cycle control, including Cdc25A and Cdc25C (Falck et al., 2002) and mediates repression of gene transcription J. Appl.”
BackgroundJang, E. R., Lee, J., Lim, D., & Lee, J. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0522-y · Cited by 20
“2001), or it may regulate the G2/M transition by regulating Cdc25C (Falck et al. 2002; Matsuoka et al. 1998; Blasina et al. 1999).”
BackgroundDNA damage response is hijacked by human papillomaviruses to complete their life cycle
Hong, S.-Y. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600306 · Cited by 19
“In addition, the activated CHK2 can phosphorylate Cdc25A and p53.”
InfluentialDNA repair functional analyses of NBN hypomorphic variants associated with NBN‐related infertility
Fiévet, A., Bellanger, D., Zahed, L. F., Bürglen, L., Derrien, A., d’Enghien, C. D., Lespinasse, J., Parfait, B., Pedespan, J., Rieunier, G., et al. (2019) · Human Mutation · doi:10.1002/humu.23955 · Cited by 18
Autophosphorylated Residues Involved in the Regulation of Human Chk2 In Vitro
Gabant, G., Lorphelin, A., Nozerand, N., Marchetti, C., Bellanger, L., Dedieu, A., Quéméneur, É., & Alpha‐Bazin, B. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.053 · Cited by 20
“The S/T-rich N-terminal tryptic peptide [4–95], containing Ser19, Ser33/35 and Thr68, was detected using MALDI-TOF MS in linear positive mode, and its number of phosphorylated positions was estimated at 3.”
MethodCheckpoint Regulation of DNA Replication
Boye, E., Skjølberg, H. C., & Grallert, B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-815-7_4 · Cited by 21
Genome instability and Rad50S: subtle yet severe
de Jager, M., & Kanaar, R. (2002) · Genes & Development · doi:10.1101/gad.1025402 · Cited by 20
“Furthermore, the complex plays a role in the resolution of aberrant DNA structures that arise when replication forks pass through repeated sequences (Cromie et al. 2001; Farah et al. 2002; Lobachev et al. 2002).”
BackgroundCondensin recruitment to chromatin is inhibited by Chk2 kinase in response to DNA damage
Zhang, T., Si-Hoe, S. L., Hudson, D. F., & Surana, U. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1249075 · Cited by 16
APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
Xie, X., Fan, C., Luo, B., Zhang, J., Jensen, L. D., Burman, J., Jönsson, C., Ljusberg, A., Larsson, P., Zhao, Z., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0275 · Cited by 18
“0 Gy/h might be attributed to the DNA damage response in the S-phase checkpoint (40).”
Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0 · Cited by 16
Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions
Dzikiewicz‐Krawczyk, A., Mosor, M., Januszkiewicz, D., & Nowak, J. (2011) · Mutagenesis · doi:10.1093/mutage/ger084 · Cited by 17
“Cells from NBS patients display an intermediate RDS phenotype compared to ataxia telangiectasia cells and control cells (4).”
ResultCdc2 Tyrosine Phosphorylation is Not Required for the S-Phase DNA Damage Checkpoint in Fission Yeast
Kommajosyula, N., & Rhind, N. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3423 · Cited by 16
Progress Towards the Anatomy of the Eukaryotic DNA Replication Fork
Nasheuer, H., Pospiech, H., & Syväoja, J. E. (2006) · Springer eBooks · doi:10.1007/7050_016 · Cited by 18
“This seems to be a conserved mechanism, since it was also observed in humans (Falck et al. 2002).”
BackgroundDNA damage checkpoints in nasopharyngeal carcinoma
Poon, R. Y. C. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.009 · Cited by 15
“quired for folk slowing [24].”
DNA damage to human genetic disorders with neurodevelopmental defects
Lee, Y., Choi, I., Kim, J., & Kim, K. (2016) · Journal of genetic medicine · doi:10.5734/jgm.2016.13.1.1 · Cited by 15
Highlight: BRCA1 and BRCA2 proteins in breast cancer
Daniel, D. C. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10178 · Cited by 23
“The authors concluded that these phosphorylated substrates cooperatively inhibited distinct steps of DNA replication (Falck et al., 2002).”
Wu, X.-Y., Qian, J., Lin, Y., & Zheng, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.012 · Cited by 14
Dual role of Nbs1 in the ataxia telangiectasia mutated‐dependent DNA damage response
Lee, J., & Lim, D. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05191.x · Cited by 18
Response to environmental carcinogens in DNA-repair-deficient disorders
Digweed, M. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00292-0 · Cited by 16
TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
Arroyo, M., Fernández-Mimbrera, M. Á., Gollini, E., Esteve‐Codina, A., Sánchez, A., & Marchal, J. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-87895-8 · Cited by 17
“This is probably a consequence of the massive occurrence of DSBs in the DNA that interfere with the replication process 21,27–29 .”
Soni, A., Duan, X., Stuschke, M., & Iliakis, G. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147506 · Cited by 14
Alster, O., Bielak-Żmijewska, A., Mosieniak, G., Moreno‐Villanueva, M., Dudka, W., Wojtala, A., Kusio-Kobiałka, M., Korwek, Z., Bürkle, A., Piwocka, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104964 · Cited by 13
Traffic safety for the cell: Influence of cyclin-dependent kinase activity on genomic stability
Enders, G. H., & Maude, S. L. (2006) · Gene · doi:10.1016/j.gene.2005.11.017 · Cited by 16
Arnould, S., Spanswick, V. J., Macpherson, J. S., Hartley, J. A., Thurston, D. E., Jodrell, D. I., & Guichard, S. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0018 · Cited by 14
Transcription coupled repair deficiency protects against human mutagenesis and carcinogenesis
Cleaver, J. E. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.08.004 · Cited by 14
Gou, Q., Xie, Y., Liu, L., Xie, K., Wu, Y., Wang, Q., Wang, Z., & Li, P. (2015) · Oncology Reports · doi:10.3892/or.2015.3980 · Cited by 12
Cell-Cycle Control and DNA-Damage Signaling in Mammals
Gómez, V., & Hergovich, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00014-8 · Cited by 16
Evangelisti, G., Barra, F., Moioli, M., Sala, P., Stigliani, S., Gustavino, C., Costantini, S., & Ferrero, S. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1783238 · Cited by 13
Pan, X., Mou, J., Liu, S., Sun, Z., Meng, R., Zhou, Z., Wu, G., & Peng, G. (2015) · Oncology Reports · doi:10.3892/or.2015.3939 · Cited by 12
Stracker, T. H., & Petrini, J. H. J. (2008) · Cell Cycle · doi:10.4161/cc.7.23.7064 · Cited by 15
Self-citationPorter-Goff, M. E., & Rhind, N. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-09-0986 · Cited by 14
“Cells of ATLD and NBS patients show an intermediate overall slowing of replication (Young and Painter, 1989; Falck et al., 2002).”
BackgroundHdm2- and proteasome-dependent turnover limits p21 accumulation during S phase
Ciznadija, D., Zhu, X.-H., & Koff, A. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16725 · Cited by 11
“In S-phase cells, checkpoints are triggered by multiple mechanisms involving both the inhibition of cdc25A, which removes an inhibitory phosphorylation on cyclin-cdk complexes, and the MRN complex.(9-12) In G 2 cells, inactivation of cdc25 prevents the activation of cyclin B-cdc2, and in some cell types, p53-dependent…”
BackgroundAlpha‐Bazin, B., & Quéméneur, É. (2012) · Analytical Chemistry · doi:10.1021/ac3021505 · Cited by 11
Ventura, E., & Giordano, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.90189-4 · Cited by 13
The Cdc25A is involved in S-phase checkpoint induced by benzo(a)pyrene
Yao, B., Fu, J., Hu, E., Qi, Y., & Zhou, Z. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.015 · Cited by 11
Methods to Study Cancer Therapeutic Drugs That Target Cell Cycle Checkpoints
Dai, Y., & Grant, S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-273-1_19 · Cited by 10
Rollando, R. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i7.25607 · Cited by 10
“increases its sensitivity toward chemotherapeutic agent [19].”
Liao, H., Yang, S., Liang, Z., Lin, X., Xie, S., Lin, P., Xia, F., Fang, C., Chen, Q., Ling, D., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c06774 · Cited by 9
Willis, N. A., & Rhind, N. (2010) · Genetics · doi:10.1534/genetics.109.113019 · Cited by 14
Minor Kinases with Major Roles in Cytokinesis Regulation
Sechi, S., Piergentili, R., & Giansanti, M. G. (2022) · Cells · doi:10.3390/cells11223639 · Cited by 10
“In turn, Chk2 regulates multiple targets through phosphorylation; beyond the above-mentioned BRCA1 [218], E2F-1 [215], and Cdc25 [210], its interactors also include the NBS1/MRE11 axis [219], the inducer of acute promyelocytic leukemia, PML, [220], and the ATR/ATM/p53 pathway, both of which induce apoptosis [221].”
BackgroundYamaguchi, K., Horie, C., Takane, K., Ikenoue, T., Nakagawa, S., Isobe, Y., Ota, Y., Ushiku, T., Tanaka, M. H., Fujishiro, J., et al. (2022) · Cancer Science · doi:10.1111/cas.15657 · Cited by 7
Phosphorylation Mediated Regulation of Cdc25 Activity, Localization and Stability
Frazer, C., & Young, P. G. (2012) · InTech eBooks · doi:10.5772/48315 · Cited by 9
“[179,180] Defects in the Intra-S checkpoint allow replication of damaged DNA.”
BackgroundCoping with DNA Double-Strand Breaks via ATM Signaling Pathway in Bovine Oocytes
Wang, L., Xu, X., Teng, M., Zhao, G., & Lei, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238892 · Cited by 8
“When activated, p53 triggers the p21/WAF1 pathway, which affects the activity of cyclin kinases and blocks cell progression from the G1 phase to the S phase [24].”
BackgroundPuts, G. S., Jarrett, S. G., Leonard, M. K., Matsangos, N., Snyder, D. E., Wang, Y., Vincent, R., Portney, B. A., Abbotts, R., McLaughlin, L. J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165896 · Cited by 6
“4-OHT inducible translocation of I-PpoI and DSB induction was further demonstrated by the rapid and transient phosphorylation of Chk2, an ATM substrate that governs checkpoint responses following DNA damage [34].”
BackgroundMethodInfluentialEffective intra‐S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines
Cordeiro‐Stone, M., McNulty, J. J., Sproul, C. D., Chastain, P. D., Gibbs-Flournoy, E. A., Zhou, Y., Carson, C. C., Rao, S., Mitchell, D. L., Simpson, D. A., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12426 · Cited by 6
“Both the ATM- and ATR-generated intra-S checkpoint signaling pathways may converge to evict Cdc45 from the replicative helicase complex on chromatin (Falck et al., 2002; Liu et al., 2006).”
BackgroundLi, E., Ho, R., Tao, R., Choi, Y. W. Y., Shin, C. Y., Chen, S. Y., Gokbayrak, B., Senz, J., Yao, B., Johnston, L., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01053-x · Cited by 6
“Ithas multiplerolesincellcyclecheckpointcontrolanditsfunctionisoften redundantwiththatofCDK1 42,43 .”
Targeting cell cycle checkpoints for glioma therapy
Lang, F., & Yang, C. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108932 · Cited by 6
Vogel, S., & Herzinger, T. (2013) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12071 · Cited by 5
“The checkpoint response to IR requires Atm, meiotic recombination 11 (MRE-11), and Nbs1 (13, 14).”
BackgroundMolecular Genetics and Cancer Biology
Gonzalgo, M. L., & Meeker, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00018-9 · Cited by 5
Nowak, J., Świątek-Kościelna, B., Kałużna, E. M., Rembowska, J., Dzikiewicz‐Krawczyk, A., Zawada, M., & Januszkiewicz‐Lewandowska, D. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65452 · Cited by 5
“R215W NBN gene mutations? It was found that nibrin is involved in activation of S phase checkpoint through the mechanism regulated by ataxia telangiectasia-mutated protein kinase [16].”
BackgroundANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells
Dhyani, A., Favaro, P. M. B., & Saad, S. T. O. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102460 · Cited by 6
Radiation Induced DNA Damage, Repair and Therapeutics
Harrison, L. (2013) · CRC Press eBooks · doi:10.1201/b14587-14 · Cited by 5
ATM , ATR and Mre11 complex genes in hereditary susceptibility to breast cancer
Pylkäs, K. (2007) · Cited by 5
Cell cycle control and DNA-damage signaling in mammals
Gündoğdu, R., Hergovich, A., & Gómez, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00014-3 · Cited by 5
Metadata
- Authors
- Falck, J., Petrini, J. H. J., Williams, B. R., Lukas, J., & Bartek, J.
- Affiliations
- Danish Cancer Society (DK)
- University of Wisconsin–Madison (US)
- Venue
- Nature Genetics
- Published
- 2002-02-19
- Volume
- 30
- Issue
- 3
- Pages
- 290-294
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2104788350
- Cited by
- 392
- References
- 30
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 13 · 2013: 16 · 2012: 16
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- S-phase checkpoint, DNA damage response, ionizing radiation, ATM kinase, NBS1, MRE11, Chk2, CDC25A, CDK2, radioresistant DNA synthesis, DNA replication, parallel signaling pathways, Chk2 phosphorylation
- MeSH terms
- Cell Line, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Kinases, Radiation, Ionizing, S Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, cdc25 Phosphatases, Tumor Suppressor Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase 2, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.